Ten years of anti-HPV vaccinations: what do we know?
Human papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At present, the degree of i...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-11-01
|
Series: | Menopause Review |
Subjects: | |
Online Access: | https://www.termedia.pl/Ten-years-of-anti-HPV-vaccinations-what-do-we-know-,4,28662,1,1.html |
id |
doaj-63b4d982a9844b66acf71e27b9efa19b |
---|---|
record_format |
Article |
spelling |
doaj-63b4d982a9844b66acf71e27b9efa19b2020-11-24T23:47:16ZengTermedia Publishing HouseMenopause Review1643-88762299-00382016-11-0115317017510.5114/pm.2016.6349728662Ten years of anti-HPV vaccinations: what do we know?Robert JachAntoni BastaJan KotarskiJanina MarkowskaTomasz PaszkowskiRomuald DębskiWojciech RokitaWitold KędziaKrystyna KiszkaHuman papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At present, the degree of implementation of these recommendations depends on a number of country-specific factors such as the health care system organization or the ways of funding. HPV vaccines are primarily to prevent the development of cervical cancer and other genital cancers. Therefore, only their long-term effectiveness can be measured, when a correspondingly large cohort of vaccinated teenagers reaches the age of the greatest incidence of these cancers. However, great care should be taken in assessing the results of vaccinations due to the possibility of misinterpretation and possible erroneous data. Undoubtedly, teenagers are the target population of HPV vaccines. However, vaccinating young sexually active women is also justified from an individual point of view. A 9-valent vaccine has been registered in the USA and in Europe – including Poland – as one of the three preventive vaccines. It is recommended to vaccinate women between 13 and 26 and men between 13 and 21, previously unvaccinated. It is also recommended to vaccinate men aged 26 years or less who have sexual relations with other men and people with reduced immunity, including HIV-positive people who have not been vaccinated previously.https://www.termedia.pl/Ten-years-of-anti-HPV-vaccinations-what-do-we-know-,4,28662,1,1.htmlHPV human papillomavirus HPV vaccine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Robert Jach Antoni Basta Jan Kotarski Janina Markowska Tomasz Paszkowski Romuald Dębski Wojciech Rokita Witold Kędzia Krystyna Kiszka |
spellingShingle |
Robert Jach Antoni Basta Jan Kotarski Janina Markowska Tomasz Paszkowski Romuald Dębski Wojciech Rokita Witold Kędzia Krystyna Kiszka Ten years of anti-HPV vaccinations: what do we know? Menopause Review HPV human papillomavirus HPV vaccine |
author_facet |
Robert Jach Antoni Basta Jan Kotarski Janina Markowska Tomasz Paszkowski Romuald Dębski Wojciech Rokita Witold Kędzia Krystyna Kiszka |
author_sort |
Robert Jach |
title |
Ten years of anti-HPV vaccinations: what do we know? |
title_short |
Ten years of anti-HPV vaccinations: what do we know? |
title_full |
Ten years of anti-HPV vaccinations: what do we know? |
title_fullStr |
Ten years of anti-HPV vaccinations: what do we know? |
title_full_unstemmed |
Ten years of anti-HPV vaccinations: what do we know? |
title_sort |
ten years of anti-hpv vaccinations: what do we know? |
publisher |
Termedia Publishing House |
series |
Menopause Review |
issn |
1643-8876 2299-0038 |
publishDate |
2016-11-01 |
description |
Human papillomavirus (HPV) is one of the most important carcinogens in humans. Vaccines against HPV are now considered the first anti-cancer vaccinations. Since 2007, in many developed countries, there have been recommendations present for preventive vaccines against HPV. At present, the degree of implementation of these recommendations depends on a number of country-specific factors such as the health care system organization or the ways of funding. HPV vaccines are primarily to prevent the development of cervical cancer and other genital cancers. Therefore, only their long-term effectiveness can be measured, when a correspondingly large cohort of vaccinated teenagers reaches the age of the greatest incidence of these cancers. However, great care should be taken in assessing the results of vaccinations due to the possibility of misinterpretation and possible erroneous data.
Undoubtedly, teenagers are the target population of HPV vaccines. However, vaccinating young sexually active women is also justified from an individual point of view. A 9-valent vaccine has been registered in the USA and in Europe – including Poland – as one of the three preventive vaccines. It is recommended to vaccinate women between 13 and 26 and men between 13 and 21, previously unvaccinated. It is also recommended to vaccinate men aged 26 years or less who have sexual relations with other men and people with reduced immunity, including HIV-positive people who have not been vaccinated previously. |
topic |
HPV human papillomavirus HPV vaccine |
url |
https://www.termedia.pl/Ten-years-of-anti-HPV-vaccinations-what-do-we-know-,4,28662,1,1.html |
work_keys_str_mv |
AT robertjach tenyearsofantihpvvaccinationswhatdoweknow AT antonibasta tenyearsofantihpvvaccinationswhatdoweknow AT jankotarski tenyearsofantihpvvaccinationswhatdoweknow AT janinamarkowska tenyearsofantihpvvaccinationswhatdoweknow AT tomaszpaszkowski tenyearsofantihpvvaccinationswhatdoweknow AT romualddebski tenyearsofantihpvvaccinationswhatdoweknow AT wojciechrokita tenyearsofantihpvvaccinationswhatdoweknow AT witoldkedzia tenyearsofantihpvvaccinationswhatdoweknow AT krystynakiszka tenyearsofantihpvvaccinationswhatdoweknow |
_version_ |
1725490689783889920 |